Clinical Trial

ABCG8, UGT1A1 and Gallstone Disease After Bariatric Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational genetic case-control study is to learn whether two specific genetic variants in ABCG8 and UGT1A1 are associated with gallstone disease after bariatric surgery. The study includes adults who have previously undergone bariatric surgery. The main questions it aims to answer are whether the ABCG8 D19H variant and the UGT1A1 rs6742078 variant are associated with an increased risk of gallstone disease requiring cholecystectomy after bariatric surgery. Researchers will compare patients who underwent bariatric surgery and later had their gallbladder removed because of gallstone disease with patients who underwent bariatric surgery but did not develop gallstone disease or undergo cholecystectomy during follow-up. Participants will provide one blood sample for targeted genetic analysis and complete questionnaires about health, previous surgery, medication use, family history, and gastrointestinal quality of life. Relevant clinical information will also be collected from medical records.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-09.
Trial Details
NCT Number NCT07702630
Lead Sponsor Esbjerg Hospital - University Hospital of Southern Denmark
Collaborators: Odense University Hospital, University of Southern Denmark
Conditions Gallstone Disease, Bariatric Surgery, Metabolic Surgery, Cholecystectomy, Genetics
Enrollment 270 participants
Start Date 2026-10-01
Primary Completion 2029-01-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17